Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis

NCT00439283 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: infliximab
DRUG: methotrexate

Sponsor

Association de Recherche Clinique en Rhumatologie